NAYA Biosciences Debt to Equity Ratio 2010-2024 | IVF
Current and historical debt to equity ratio values for NAYA Biosciences (IVF) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. NAYA Biosciences debt/equity for the three months ending September 30, 2024 was 0.00.
| NAYA Biosciences Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-09-30 |
$0.02B |
$0.00B |
-731.45 |
| 2024-06-30 |
$0.02B |
$0.00B |
12.02 |
| 2024-03-31 |
$0.02B |
$0.00B |
1794.86 |
| 2023-12-31 |
$0.02B |
$0.00B |
19.73 |
| 2023-09-30 |
$0.02B |
$0.00B |
51.24 |
| 2023-06-30 |
$0.01B |
$0.00B |
-4.89 |
| 2023-03-31 |
$0.01B |
$0.00B |
68.51 |
| 2022-12-31 |
$0.01B |
$0.00B |
-4.80 |
| 2022-09-30 |
$0.00B |
$0.00B |
2.63 |
| 2022-06-30 |
$0.00B |
$0.00B |
0.91 |
| 2022-03-31 |
$0.00B |
$0.01B |
0.52 |
| 2021-12-31 |
$0.00B |
$0.01B |
0.43 |
| 2021-09-30 |
$0.01B |
$0.00B |
2.46 |
| 2021-06-30 |
$0.01B |
$0.00B |
1.28 |
| 2021-03-31 |
$0.01B |
$0.01B |
0.82 |
| 2020-12-31 |
$0.01B |
$0.01B |
0.91 |
| 2020-09-30 |
$0.01B |
$0.00B |
-1.43 |
| 2020-06-30 |
$0.01B |
$0.00B |
-1.64 |
| 2020-03-31 |
$0.01B |
$0.00B |
-1.22 |
| 2019-12-31 |
$0.01B |
$0.00B |
-1.48 |
| 2019-09-30 |
$0.01B |
$0.00B |
-1.68 |
| 2019-06-30 |
$0.01B |
$0.00B |
-2.08 |
| 2019-03-31 |
$0.01B |
$0.00B |
-2.13 |
| 2018-12-31 |
$0.00B |
$0.00B |
-1.29 |
| 2018-09-30 |
$0.01B |
$0.00B |
-1.21 |
| 2018-06-30 |
$0.01B |
$0.00B |
-1.28 |
| 2018-03-31 |
$0.01B |
$-0.01B |
-1.06 |
| 2017-12-31 |
$0.01B |
$-0.01B |
-1.05 |
| 2017-09-30 |
$0.01B |
$-0.01B |
-1.04 |
| 2017-06-30 |
$0.01B |
$-0.01B |
-1.04 |
| 2017-03-31 |
$0.01B |
$-0.01B |
-1.04 |
| 2016-12-31 |
$0.01B |
$-0.01B |
-1.06 |
| 2016-09-30 |
$0.01B |
$0.00B |
-1.09 |
| 2016-06-30 |
$0.01B |
$0.00B |
-1.11 |
| 2016-03-31 |
$0.00B |
$0.00B |
-1.14 |
| 2015-12-31 |
$0.00B |
$0.00B |
-1.15 |
| 2015-09-30 |
$0.00B |
|
0.00 |
| 2015-06-30 |
$0.00B |
|
0.00 |
| 2015-03-31 |
$0.00B |
|
0.00 |
| 2011-12-31 |
$0.00B |
$0.00B |
-1.04 |
| 2011-09-30 |
$0.00B |
$0.00B |
-1.05 |
| 2011-06-30 |
$0.00B |
$0.00B |
-1.05 |
| 2011-03-31 |
$0.00B |
$0.00B |
-1.06 |
| 2010-12-31 |
$0.00B |
$0.00B |
-1.07 |
| 2010-09-30 |
$0.00B |
$0.00B |
-1.07 |
| 2010-06-30 |
$0.00B |
$0.00B |
-1.08 |
| 2010-03-31 |
$0.00B |
$0.00B |
-1.09 |
| 2009-12-31 |
$0.00B |
$0.00B |
-1.09 |
| 2009-09-30 |
$0.01B |
$-0.01B |
-1.10 |
| 2009-06-30 |
$0.00B |
$0.00B |
-1.18 |
| 2009-03-31 |
$0.00B |
$0.00B |
-1.28 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.002B |
$0.007B |
|
NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
|
